NASDAQ:ARQT | Insider Transactions — Page 4 | Arcutis Biotherapeutics, Inc.

ARQT Insider Transactions — Page 4

414 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–400; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Watanabe Todd FranklinPresident and CEO2022-01-05Sale600.0$21.11
Watanabe Todd FranklinPresident and CEO2022-01-05Sale100.0$22.06
Watanabe Todd FranklinPresident and CEO2022-01-05Sale300.0$22.4
Welgus Howard G.Director2022-01-03Sale2,500.0$21.21
Burrows Scott LChief Financial Officer2021-12-27Sale12,560.0$20.07
Welgus Howard G.Director2021-12-23Sale2,500.0$20.16
Watanabe Todd FranklinPresident and CEO2021-12-08Sale1,000.0$17.0
Watanabe Todd FranklinPresident and CEO2021-11-05Sale1,000.0$21.5
Welgus Howard G.Director2021-11-01Sale2,500.0$21.81
Watanabe Todd FranklinPresident and CEO2021-10-05Sale2,500.0$24.92
Welgus Howard G.Director2021-10-01Sale2,500.0$23.87
Watanabe Todd FranklinPresident and CEO2021-10-01Sale1,500.0$25.01
Watanabe Todd FranklinPresident and CEO2021-09-07Sale1,000.0$21.14
Welgus Howard G.Director2021-09-01Sale800.0$21.28
Welgus Howard G.Director2021-09-01Sale4,200.0$20.71
Watanabe Todd FranklinPresident and CEO2021-08-05Sale1,000.0$20.81
Watanabe Todd FranklinPresident and CEO2021-07-06Sale1,750.0$26.58
Welgus Howard G.Director2021-07-01Sale250.0$26.87
Welgus Howard G.Director2021-07-01Sale1,950.0$26.03
CHAUDHURI BHASKARDirector2021-06-25Sale6,755.0$27.5
CHAUDHURI BHASKARDirector2021-06-24Sale729.0$27.5
CHAUDHURI BHASKARDirector2021-06-21Sale2,516.0$27.5
Watanabe Todd FranklinPresident and CEO2021-06-07Sale1,750.0$26.35
CHAUDHURI BHASKARDirector2021-06-01Sale10,000.0$27.5
Welgus Howard G.Director2021-06-01Sale142.0$27.61
Welgus Howard G.Director2021-06-01Sale2,058.0$27.06
Watanabe Todd FranklinPresident and CEO2021-05-07Sale750.0$35.0
Watanabe Todd FranklinPresident and CEO2021-05-05Sale1,750.0$34.0
Welgus Howard G.Director2021-05-03Sale917.0$35.12
Welgus Howard G.Director2021-05-03Sale1,283.0$34.56
Watanabe Todd FranklinPresident and CEO2021-04-30Sale1,500.0$35.0
CHAUDHURI BHASKARDirector2021-04-20Sale1,280.0$28.53
CHAUDHURI BHASKARDirector2021-04-20Sale8,720.0$27.99
CHAUDHURI BHASKARDirector2021-04-20Sale1,280.0$28.53
CHAUDHURI BHASKARDirector2021-04-20Sale8,720.0$27.99
Watanabe Todd FranklinPresident and CEO2021-04-05Sale1,750.0$29.93
Welgus Howard G.Director2021-04-01Sale1,040.0$29.75
Welgus Howard G.Director2021-04-01Sale1,160.0$29.25
CHAUDHURI BHASKARDirector2021-03-22Sale4,992.0$31.43
CHAUDHURI BHASKARDirector2021-03-22Sale5,008.0$30.77
Smither John WChief Financial Officer2021-03-10Sale1,250.0$32.9
Smither John WChief Financial Officer2021-03-10Sale500.0$32.9
Watanabe Todd FranklinPresident and CEO2021-03-05Sale1,750.0$30.55
Watanabe Todd FranklinPresident and CEO2021-03-02Sale2,107.0$35.19
OSBORNE DAVID WChief Technical Officer2021-03-01Sale780.0$34.57
Turney Patricia A.SVP, Operations2021-03-01Sale934.0$34.52
Smither John WChief Financial Officer2021-03-01Sale773.0$34.2
Lock Kenneth A.Chief Commercial Officer2021-03-01Sale933.0$34.2
Welgus Howard G.Director2021-03-01Sale166.0$34.88
Welgus Howard G.Director2021-03-01Sale2,034.0$34.33
CHAUDHURI BHASKARDirector2021-02-22Sale2,789.0$35.97
CHAUDHURI BHASKARDirector2021-02-22Sale7,211.0$35.34
Smither John WChief Financial Officer2021-02-10Sale2,000.0$35.64
Smither John WChief Financial Officer2021-02-10Sale750.0$35.64
Watanabe Todd FranklinPresident and CEO2021-02-05Sale6,700.0$34.61
Watanabe Todd FranklinPresident and CEO2021-02-05Sale3,300.0$33.64
Welgus Howard G.Director2021-02-01Sale50.0$36.0
Welgus Howard G.Director2021-02-01Sale350.0$35.02
Welgus Howard G.Director2021-02-01Sale1,250.0$34.49
Welgus Howard G.Director2021-02-01Sale550.0$33.45
Smither John WChief Financial Officer2021-02-01Sale3,750.0$35.0
Smither John WChief Financial Officer2021-02-01Sale1,250.0$35.0
CHAUDHURI BHASKARDirector2021-02-01Sale9,949.0$33.25
CHAUDHURI BHASKARDirector2021-01-29Sale51.0$27.5
Smither John WChief Financial Officer2021-01-19Sale1,250.0$30.0
Smither John WChief Financial Officer2021-01-19Sale500.0$30.0
Watanabe Todd FranklinPresident and CEO2021-01-05Sale10,000.0$28.08
Welgus Howard G.Director2021-01-04Sale2,200.0$27.82
OSBORNE DAVID WChief Technical Officer2020-12-14Sale15,000.0$30.0
Smither John WChief Financial Officer2020-12-14Sale3,750.0$30.0
Smither John WChief Financial Officer2020-12-14Sale1,500.0$30.0
Welgus Howard G.Director2020-12-01Sale263.0$27.36
Welgus Howard G.Director2020-12-01Sale1,050.0$26.29
Welgus Howard G.Director2020-12-01Sale887.0$25.2
Welgus Howard G.Director2020-11-02Sale2,200.0$18.27
ORBIMED ADVISORS LLCDirector,TenPercentOwner2020-10-02Purchase296,000.0$25.0
ORBIMED CAPITAL LLCDirector,TenPercentOwner2020-10-02Purchase296,000.0$25.0
OrbiMed Capital GP VII LLCDirector,TenPercentOwner2020-10-02Purchase296,000.0$25.0
ORBIMED ADVISORS LLCDirector,TenPercentOwner2020-10-02Purchase200,000.0$25.0
ORBIMED CAPITAL LLCDirector,TenPercentOwner2020-10-02Purchase200,000.0$25.0
OrbiMed Capital GP VII LLCDirector,TenPercentOwner2020-10-02Purchase200,000.0$25.0
SILVERSTEIN JONATHANDirector,TenPercentOwner2020-10-02Purchase296,000.0$25.0
SILVERSTEIN JONATHANDirector,TenPercentOwner2020-10-02Purchase200,000.0$25.0
Welgus Howard G.Director2020-10-01Sale390.0$25.18
Welgus Howard G.Director2020-10-01Sale1,810.0$28.18
Watanabe Todd FranklinPresident and CEO2020-09-29Sale3,000.0$30.0
Watanabe Todd FranklinPresident and CEO2020-09-29Sale3,000.0$30.0
OSBORNE DAVID WChief Technical Officer2020-09-29Sale15,000.0$30.0
Smither John WChief Financial Officer2020-09-29Sale1,250.0$30.0
Smither John WChief Financial Officer2020-09-29Sale500.0$30.0
Welgus Howard G.Director2020-09-01Sale1,172.0$24.38
Welgus Howard G.Director2020-09-01Sale1,028.0$24.38
Welgus Howard G.Director2020-09-01Sale2,200.0$24.38
Welgus Howard G.Director2020-08-03Sale67.0$25.63
Welgus Howard G.Director2020-08-03Sale2,733.0$25.63
Heron Patrick JDirector,TenPercentOwner2020-02-04Purchase500,000.0$17.0
Topper James NTenPercentOwner2020-02-04Purchase500,000.0$17.0
Frazier Life Sciences VIII, L.P.TenPercentOwner2020-02-04Purchase500,000.0$17.0
FHM LIFE SCIENCES VIII, L.P.TenPercentOwner2020-02-04Purchase500,000.0$17.0
FHM LIFE SCIENCES VIII, L.L.C.TenPercentOwner2020-02-04Purchase500,000.0$17.0